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Although eukaryotic nuclei contain distinct architec-
tural structures associated with noncoding RNAs
(ncRNAs), their potential relationship to regulated
transcriptional programs remains poorly understood.
Here, we report that methylation/demethylation of
Polycomb 2 protein (Pc2) controls relocation of
growth-control genes between Polycomb bodies
(PcGs) and interchromatin granules (ICGs) in re-
sponse to growth signals. This movement is the
consequence of binding of methylated and unmethy-
lated Pc2 to the ncRNAs TUG1 andMALAT1/NEAT2,
located in PcGs and ICGs, respectively. These
ncRNAs mediate assembly of multiple corepressors/
coactivators andcan serve to switchmark recognition
by ‘‘readers’’ of thehistonecode.Additionally,binding
of NEAT2 to unmethylated Pc2 promotes E2F1 SU-
MOylation, leading to activation of the growth-control
geneprogram.Theseobservations delineate amolec-
ular pathway linking the actions of subnuclear struc-
ture-specific ncRNAs and nonhistone protein methyl-
ation to relocation of transcription units in the three-
dimensional space of the nucleus, thus achieving
coordinated gene expression programs.
INTRODUCTION
Regulated programs of gene expression are defined by the
concerted interplay of transcriptional factors as well as other
modulators such as epigenomic and signaling mediators.
Recent studies have begun to elucidate the mechanistic control
of gene expression by modulation of nuclear architecture and
noncoding RNA (ncRNA) (Mercer et al., 2009; Misteli, 2010;
Wilusz et al., 2009), suggesting the crosstalk between subnu-clear architectural features and ncRNA as a possible mechanism
for controlling gene expression. Thus, a growing number and
type of molecular strategies combinatorially contribute to the
precise control of gene expression involved in proliferation, dif-
ferentiation, and maturation of cells.
In regulation of cell proliferation, the E2F family of transcription
factors plays a critical role in organizing early cell-cycle progres-
sion by coordinating early cell-cycle events with the transcription
of genes required for entry into S phase (Nevins, 1992). The tran-
scriptional activity of E2F1 is regulated principally by associa-
tion with different factors including the Rb–E2F complexes,
which predominate in quiescent cells, acting as repressors of
transcription (Bagchi et al., 1991). Other levels of control that
influence E2F1 activity include its posttranslational modifica-
tions, protein stabilization (Campanero and Flemington, 1997),
and regulation of its intracellular location (de la Luna et al., 1996).
At the level of ‘‘epigenomic control,’’ a large and growing class
of proteins, known as chromatin modifiers, constrains expres-
sion by adapting regions of the genome to maintain either gene
silencing or gene activation (Kouzarides, 2007). Histone methyl-
ation, together with other site-specific modifications, plays an
important role in the generation of specific molecular marks in
chromatin, which are recognized by regulatory proteins, thus
determining dynamic transitions between transcriptionally active
and inactive states (Jenuwein and Allis, 2001). Recent data
also show that the regulatory role of lysine methylation on
proteins is not restricted to the ‘‘histone code’’ with thismodifica-
tion modulating activation, stabilization, and degradation of
nonhistone proteins, thus influencing numerous cell processes
(Huang and Berger, 2008). A number of histone methyltrans-
ferases (HMTases) that can methylate specific lysine residues
of histones and certain nonhistone substrates have been identi-
fied and characterized (Chuikov et al., 2004; Sampath et al.,
2007; Subramanian et al., 2008). Suv39h1 is an H3 lysine 9
methyltransferase containing the conserved SET domain and
post-SET domains (Aagaard et al., 1999). It is documented that
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repression and gene silencing by recruitment of Polycomb pro-
teins and forming and spreading heterochromatin (Lachner
et al., 2001).
Genetic study of Suv39h1 transgenic mice has demonstrated
that overexpression of Suv39h1 accelerates homeostatic cell
proliferation (Czvitkovich et al., 2001), whereas Suv39h1/h2
double null mice have reduced viability during embryonic devel-
opment and reduced growth as adult animals (Peters et al.,
2001). Furthermore, Suv39h1 forms a complex with pRb/E2F1
and plays a role in the dynamic regulation of specific cell-cycle
genes needed for entry into the S phase (Ait-Si-Ali et al., 2004;
Nielsen et al., 2001). These observations suggest that Suv39h1
may function as a transcriptional corepressor of the E2F1 tran-
scription factor. Indeed, Suv39h1 selectively interacts with ver-
tebrate chromobox family (Cbx) proteins, including hetero-
chromatin protein 1 (HP1) and Cbx4 (Pc2) (Sewalt et al., 2002).
Although Cbx proteins are thought to function as repressors in
heterochromatin formation and gene silencing, recent evidence
has demonstrated that Cbx proteins also play a critical role in
cell-cycle progression (Satijn et al., 1997). However, the role of
Pc2 in cell-cycle regulation remains largely unknown.
The notion that ncRNAs can have numerous molecular func-
tions is rapidly evolving (Eddy, 2001; Ponting et al., 2009).
Even though long ncRNAs represent a large class of transcrip-
tional units and appear to be evolutionarily conserved, their
specific roles in critically modulating regulated gene expression
remain poorly understood.
Here, we report a critical role of Suv39h1-mediated Pc2 meth-
ylation in regulating the cellular proliferation program, causing
a relocation of growth-control gene loci from Polycomb bodies
(PcGs) to interchromatin granules (ICGs) upon serumstimulation.
We show that ncRNAs TUG1 and NEAT2 cause the growth-
control genes to relocate from the repressive environment of
PcG bodies, where they interact with corepressor complexes,
to the gene activation milieu of the ICGs, by selectively interact-
ing with methylated and unmethylated Pc2 present on growth-
control gene promoters, respectively. Interaction with NEAT2
regulates Pc2-dependent E2F1 SUMOylation, which licenses
the recruitment of an H2B monoubiquitinase, CDCA7L, and bio-
chemically switches the Pc2 chromodomain from preferring
repressive histone marks to interacting with activation-associ-
ated histone marks. Broadly, our data highlight combinational
actions of transcription factor/coregulators, nonhistone protein
methylation, and ncRNAs resident in distinct subnuclear archi-
tectural structures as a central strategy to achieve coordinated
programs of regulated gene expression, with implications for
our understanding of the epigenomic programming in homeo-
stasis and disease.
RESULTS
Pc2 Is a Substrate for Suv39h1, a Lysine-Specific
Methyltransferase
We searched for nonhistone candidate substrates for Suv39h1
and found that Suv39h1 methylated Pc2 in vitro (Figures 1A
and S1A–S1C). Under our assay conditions, Suv39h1-mediated
methylation of Pc2 appeared to be quite specific. Other proteins
such as SUMO1, SUMO-activating enzyme E1, E2, and E2F1774 Cell 147, 773–788, November 11, 2011 ª2011 Elsevier Inc.did not serve as Suv39h1 substrates (Figure 1A). Moreover, a
Suv39h1 hyperactive mutant (H320R) (Rea et al., 2000) further
enhanced the methylation of Pc2, whereas an enzymatically
inactive Suv39h1 mutant (H324L) (Rea et al., 2000) failed to
use Pc2 as substrate (Figures 1B and S1A). Trypsin digestion
of immunoprecipitated FLAG-Pc2 from 293T cells coexpressed
with wild-type (WT) Suv39h1 (Figure 1C, arrow), followed by
mass spectrometry (MS), revealed that lysine 191 of Pc2 was
dimethylated, which was not observed in cells overexpressed
with enzymatically inactive Suv39h1 mutant (H324L) (Figure 1C
and data not shown). A single K191R point mutation completely
abolished Pc2 methylation, suggesting that K191 serves as a
sole methylation site targeted by Suv39h1 (Figures 1D and S1D).
To investigate the role of Pc2 methylation in vivo, we gener-
ated rabbit polyclonal antibodies that specifically recognized
dimethylated Pc2K191 and unmethylated Pc2 (Figure S1E). The
anti-Pc2K191-dimethyl antibody (referred to as Pc2K191me2
antibody) specifically detected bacterially purified Pc2 pro-
tein methylated by Suv39h1 in vitro but was totally unreactive
against unmethylated Pc2 protein, whereas anti-Pc2K191 anti-
body (referred to as Pc2K191 antibody) specifically recognized
unmethylated Pc2 protein with no cross-reaction to methylated
Pc2 protein when equivalent amounts of methylated and unme-
thylated Pc2 were used (Figure 1E). We concluded that the
Pc2K191me2 and Pc2K191 antibodies specifically recognized
K191-methylated and -unmethylated Pc2, respectively. To ad-
dress whether Pc2 is methylated by Suv39h1 in vivo, we
knocked down Suv39h1 and other histone H3K9 methyltrans-
ferases including Suv39h2, G9a, EuHMT, and ESET by specific
siRNAs in HeLa cells and observed that the Pc2K191me2 level
was specifically reduced only by Suv39h1 siRNA compared to
control siRNA, with a concurrent increase of unmethylated Pc2
level (Figures 1F and S1F). To rule out any potential off-target
effects of Suv39h1 siRNA,WT Suv39h1 or its enzymatically inac-
tive mutant form (H324L) was transiently expressed in HeLa
cells. Immunoblotting analysis using Pc2K191me2 antibody de-
tected increased levels of Pc2 methylation in extracts derived
from cells overexpressing theWT Suv39h1, whereas cells equiv-
alently transfected with the enzymatically inactive H324L mutant
displayed minimal, if any, Pc2 methylation (Figure 1G). The ex-
pression levels of Suv39h1 proteins and the amount of total pro-
teins in extracts were similar (Figure 1G). We therefore conclude
that Suv39h1 methylates Pc2 at K191 in vivo.
Growth-Control Gene Activation Requires KDM4C-
Mediated Pc2K191me2 Demethylation
Interestingly, Pc2K191 exists in a sequence context resembling
that of histone H3K9, which led us to search for candidate H3K9
demethylases that may demethylate Pc2K191me2. By perform-
ing an in vitro demethylation assay using active FLAG-H3K9
demethylases purified from 293T cells (Figures S2A and S2B),
we found that, in addition to histone H3K9me2, KDM4C deme-
thylated the dimethyl Pc2K191 (Figure 2A). Under our assay
conditions, KDM4C-mediated demethylation of Pc2K191me2
appeared to be quite specific, as other demethylases, including
KDM3A, KDM4A, KDM4B, KDM4C, KDM4D, and PHF8, did not
serve as Pc2K191me2 demethylases although each of the puri-
fied demethylases exhibited robust enzymatic activity on an
Figure 1. Suv39h1 Methylates Pc2 at K191
(A) Pc2 is a nonhistone substrate for Suv39h1. In vitro methylation assay was performed by incubating GST-Suv39h1 with recombinant His-Pc2, His-E2F1,
histone H3, E1, E2, and SUMO1 in the presence of [3H]-SAM.
(B) The enzymatic activity of Suv39h1 is required for Pc2 methylation. In vitro methylation assay was performed by incubating GST-Suv39h1 (WT, H320R, or
H324L mutant) with His-Pc2 in the presence of [3H]-SAM.
(C) Suv39h1 methylates Pc2 at K191 in vivo. FLAG-Pc2 immunoprecipitated from 293T cells (indicated by red arrow in left panel) was subjected to MOLDI-TOF
analysis (right panel), and modified peptides are indicated by the red box.
(D) Suv39h1methylates Pc2 at K191 in vitro. In vitro methylation assay was performed by incubating GST-Suv39h1 withWT Pc2 or K191Rmutant in the presence
of [3H]-SAM.
(E) Validation of Pc2K191me2 and Pc2K191 antibodies. Methylated and unmethylated His-Pc2 was subjected to autoradiography (top panel) or immunoblotting
with antibodies indicated (middle panels).
(F and G) Suv39h1 methylates Pc2 at K191 in vivo. Cell lysates from HeLa cells transfected with siRNAs (F) or expression vectors (G) as indicated were
immunoblotted with antibodies indicated.
For (A), (B), and (D), the reaction products were separated by SDS-PAGE followed by Coomassie blue staining (CBB) (left panel) or autoradiography (right panel).
See also Figure S1.H3K9me2 substrate (Figure S2B). Moreover, the enzymatically
inactive KDM4C-H190G/E192Amutant (Cloos et al., 2006) failed
to demethylate Pc2K191me2 (Figures 2B and S2C).
To investigate the potential role of Pc2 in cell-cycle and growth
control, we next analyzed whether KDM4C-mediated demethy-
lation of Pc2 regulates the transcriptional activation of E2F1
target genes. First, we examined whether Pc2K191me2 level is
physiologically regulated under the conditions of E2F1 activa-
tion. Immunoprecipitation experiments with Pc2K191me2 and
Pc2K191 antibodies revealed that Pc2K191me2 levels exhibiteda strong decrease in response to serum stimulation, concurrent
with increased levels of unmethylated Pc2 (Figure 2C).We further
examined the methylation status of Pc2 on E2F1 target gene
promoters previously identified by E2F1 ChIP-seq (Liu et al.,
2010), finding that Pc2K191me2 specifically enriched on E2F1
target gene promoters, in contrast to no significant occupancy
on the Actin promoter, which is not regulated by Polycomb
proteins (Figure 2D, left panel). Importantly, Pc2K191me2 levels
dramatically decreased upon serum stimulation, which corre-
lates with the increased levels of unmethylated Pc2 (Figure 2D,Cell 147, 773–788, November 11, 2011 ª2011 Elsevier Inc. 775
Figure 2. Growth-Control Gene Activation Requires KDM4C-Mediated Pc2K191me2 Demethylation
(A) KDM4C demethylates Pc2 in vitro. Histone demethylase assay was performed by incubating purified FLAG-histone demethylases with in vitro methylated
His-Pc2. Changes in substrate methylation levels were analyzed by autoradiography (upper panel) and Pc2K191me2 antibodies (middle panel). Immunoblotting
with antibodies against His tag was used to demonstrate equal loading (bottom panel).
776 Cell 147, 773–788, November 11, 2011 ª2011 Elsevier Inc.
right panel). Under the same conditions, the HoxA2 promoter,
on which Pc2 was consistently enriched, did not exhibit
Pc2K191me2 demethylation (Figure 2D).
Chromatin immunoprecipitation (ChIP) assays in HeLa cells
transfected with KDM4C WT or H190G/E192A mutant revealed
that serum stimulation resulted in increased recruitment of WT
KDM4C on E2F1 target gene promoters (Figure 2E), which cor-
related with a decreased Pc2K191me2 level (Figure 2F). The
KDM4C-H190G/E192A mutant largely inhibited Pc2K191me2
demethylation, despite being equally recruited on the same set
of promoters (Figures 2E and 2F). Indeed, siRNA-mediated
reduction of the levels of KDM4C also impaired the expression
of E2F1 target genes upon serum stimulation in HeLa cells
(Figures 2G and S2D). To further evaluate the alternative possi-
bility that the actions of KDM4C that critically dictate growth-
control gene expression might reside in its histone H3K9 deme-
thylase activity, rather than actions on Pc2K191me2, we took
advantage of the previous observations that different H3K9 de-
methylases are utilized in a promoter-specific fashion to provide
H3K9 demethylase activity (Fodor et al., 2006; Qi et al., 2010;
Yamane et al., 2006). We found that growth-control gene pro-
moters did not exhibit a KDM4C dependence on H3K9me2 de-
methylation (Figure S2E, bottom panel), yet demethylase activity
of KDM4C was required for the demethylation of Pc2K191me2
and for activation for these growth-control genes (Figures S2E,
top panel and 2G). Taken together, these data argue strongly
that it is the specific demethylation of the repressive dimethyl
Pc2K191 mark, caused by recruitment of KDM4C, rather than
H3K9 demethylation, that is required for the transcriptional acti-
vation of E2F1 target genes.
Pc2 Methylation/Demethylation Controls the
Cell-Growth Program
Considering the involvement of KDM4C-mediated Pc2K191me2
demethylation on E2F1 target gene promoters in response to
serum, we tested the possibility that Pc2 methylation/demethy-
lation is required for controlling the growth-control gene ex-
pression and cell proliferation. Knockdown of Pc2 in HeLa cells
dramatically decreased serum-induced growth-control gene ex-
pression and cell proliferation (Figures 3A, 3B, and S3A). In
accord with this finding, exogenous expression of Pc2 K191R
mutant noticeably increased cell proliferation even at the basal
level, further indicating that Pc2 is a potent regulator of the
cell-growth program (Figure 3C).(B) Enzymatic activity of KDM4C is required for Pc2K191me2 demethylation. His
His-Pc2 in the presence or absence of Fe (II). The reactions were separated by
Pc2K191me2 antibodies (middle panel), or Coomassie blue staining (lower pane
(C) Serum-induced demethylation of Pc2K191me2 in vivo. HeLa cells were serum
with Pc2K191 or Pc2K191me2 antibodies followed by immunoblotting with pan P
(D) Serum-induced demethylation of Pc2 on growth-control gene promoters. HeL
performed using Pc2K191, Pc2K191me2, and pan Pc2 antibodies on indicated re
(right panel) were normalized to the corresponding total pan Pc2 ChIP values.
(E and F) Serum-induced KDM4C recruitment is responsible for Pc2K191me2 dem
vector, FLAG-KDM4CWT, or H190G/E192A mutant were serum-starved followed
antibody (F) were performed on indicated regions.
(G) KDM4C is required for serum-induced growth-control gene expression. HeLa
followed by restimulation, and relative mRNA levels of indicated genes were det
Mean ± SEM, *p < 0.05. See also Figure S2.The potential requirement of Pc2 in mitogenic signal-induced
proliferation was next investigated in primary human fibroblasts.
IMR-90 primary human lung fibroblasts became growth arrested
with serum starvation and proliferated once released into serum-
containing medium (Nahle et al., 2002). Immunoblotting showed
that, although global Pc2 protein levels were not affected,
serum stimulation of IMR-90 cells was largely accompanied by
Pc2K191me2 demethylation (Figure 3D). Pc2 shRNAs (shPc2-1
and -2) dramatically reduced Pc2 protein levels when stably
transduced into IMR-90 cells and impaired serum-induced cell
proliferation (Figures 3E and S3B). Collectively, our data suggest
that methylated Pc2 may represent an important antimitogenic
signal and, under certain stimuli, a stress-induced modification
mark required for growth-control gene repression and cell-cycle
arrest, whereas unmethylated Pc2 is essential for physiological
growth-control gene expression and cell proliferation.
Serum Induction Causes Relocation of E2F1-Regulated
Genes between PcG Bodies and ICGs
We speculated that, given the involvement of Pc2 in stable gene
repression (Lund and van Lohuizen, 2004), E2F1-regulated
growth-control genes might relocate within the cell nuclei from
transcriptional repressive PcG bodies to a transcriptionally per-
missive environment upon serum stimulation. We first examined
the subnuclear localization of methylated and unmethylated
Pc2. We observed that methylated Pc2 was concentrated in
several defined domains that were faithfully costained with
Bmi1 and Ring1A (Figures 4A and 4B), two well-established
PcG body markers (Herna´ndez-Mun˜oz et al., 2005). In contrast,
unmethylated Pc2 showed strong colocalization only with
SC35, a marker for the ICGs (Fu and Maniatis, 1990) (Figure 4C).
Under our immunostaining conditions, colocalization of unme-
thylated Pc2 with ICGs appeared to be quite specific. Other
nuclear bodies, including nuclear stress bodies, paraspeckles,
Cajal bodies, and promyelocytic leukemia (PML) bodies, failed
to exhibit costaining with unmethylated Pc2 (data not shown).
We then performed immuno-FISH to test whether Pc2-associ-
ated E2F1 target transcription units relocated from PcG bodies
to ICGsupon serumstimulation. Interestingly, gene loci encoding
growth-control genes (RBL1, MCM3, PCNA, and MSH2) were
found to predominantly colocalize with PcG bodies, as marked
byPc2K191me2 staining (or Ring1A, seebelow) in serum-starved
HeLa cells, and these loci largely colocalized with SC35-staining
ICGs in the presence of serum (Figures 4D and S4A–S4C). Under-KDM4C WT or H190G/E192A mutant was incubated with in vitro methylated
SDS-PAGE followed by autoradiography (upper panel), immunoblotting with
l).
-starved followed by restimulation, and cell lysates were immunoprecipitated
c2 antibodies.
a cells were serum-starved followed by restimulation, and ChIP analyses were
gions. For each primer pair, Pc2K191me2 (left panel) and Pc2K191 ChIP values
ethylation on growth-control gene promoters. HeLa cells transfected with blank
by restimulation, and ChIP analyses using FLAG antibody (E) or Pc2K191me2
cells transfected with control or validated KDM4C siRNAs were serum-starved
ermined by qRT-PCR.
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Figure 3. Pc2 Methylation/Demethylation Controls Mitogenic Signal-Induced Cell Proliferation
(A and B) Pc2 is essential for serum-induced growth-control gene expression and cell proliferation. HeLa cells transfected with Pc2 siRNAs were serum-starved
followed by restimulation, and mRNA levels of indicated genes (A) and cell proliferation (B) were analyzed, respectively.
(C) Pc2K191 methylation is a key regulator for cell proliferation. HeLa cells transfected with Pc2 plasmids (WT or K191Rmutant) were serum-starved followed by
restimulation, and cell proliferation was analyzed.
(D and E) IMR-90 cells were serum-starved followed by restimulation, and Pc2K191 methylation level (D) and cell proliferation (E) were analyzed by immuno-
blotting and flow cytometry, respectively.
For (B), (C), and (E), cell proliferationwas analyzed bymonitoring the EDU incorporation into DNA synthesis in S phase cells. Mean ±SEM, *p < 0.05 and **p < 0.01.
See also Figure S3.the same conditions, colocalization of E2F1 target gene loci with
PcG bodies was reproducibly observed in immuno-FISH ex-
periments using Ring1A, instead of Pc2K191me2, staining as a
marker for PcG bodies (Figure 4E). In contrast, unmethylated
Pc2 specifically colocalized with activated E2F1 target gene
loci upon serum stimulation (Figures S4D–S4G). It was previously
shown that ICGsoccupy the large space in nuclei,which results in
a 14%–26% ‘‘unspecific’’ colocalization with genes under basal
conditions (Szczerbal and Bridger, 2010). It is to be expected
that any given gene locus may also exhibit a similar 15%–25%
‘‘unspecific’’ colocalization with ICGs. To further support this
assumption, we performed immuno-FISH on a cell-cycle-unre-
lated gene locus BCR, finding an average of 10% and 30%
colocalization of this locus with PcG bodies and ICGs in serum-
starved cells, respectively, and that these colocalization per-
centages did not change upon serum stimulation (Figure S4H).
Thus, given the assay background, the actual percent of reloca-
tion of growth-control genes from PcG bodies to ICGs would be
considerably greater if this background were to be subtracted.778 Cell 147, 773–788, November 11, 2011 ª2011 Elsevier Inc.As expected, knockdown of Pc2 impaired the colocalization of
MCM3with both PcG bodies and ICGs (Figure 4F). Interestingly,
other core components of the PRC1 complex including Bmi1
and PHC1 (Simon and Kingston, 2009) specifically interacted
with methylated Pc2 (Figure 4G), and siRNA knockdown of these
components disrupted the colocalization of MCM3 with PcG
bodies, but not ICGs, although having no obvious effects on
maintenance of PcG bodies (Figures 4F, S4I, and S4J), suggest-
ing that other components of the PRC1 complex may facilitate
the repression of growth-control genes mediated by methylated
Pc2 in PcG bodies.
We next tested whether demethylation of Pc2K191me2 is
required for the relocation process in HeLa cells microinjected
with specific siRNAs against KDM4C, and we found that deple-
tion of KDM4C largely abrogated dissociation of theMCM3 gene
locus from PcG bodies in the presence of serum stimulation (Fig-
ure 4H). In contrast, microinjection of plasmid encoding the
Pc2K191Rmutant in serum-starved cells resulted in dissociation
of the MCM3 gene locus from the Ring1A-stained PcG bodies,
while enhancing their colocalization with SC35-positive ICGs at
basal level (Figure 4I). Together, these findings reveal an unex-
pected role of Pc2 in transcriptional regulation of growth-control
genes by promoting the relocation of these gene loci from the
transcriptionally repressive nuclear environment of PcG bodies
to the transcriptionally permissive environment of ICGs. Given
the observation that siRNA knockdown of KDM4C exerted
no effect on serum-induced demethylation of H3K9me2 on
growth-control gene promoters (Figure S2E), we concluded
that the KDM4C-dependent demethylation of Pc2K191me2,
rather than histones, appears to serve as the key determinant
of the relocation of growth-control genes in response to growth
signals.
Methylation Modulates Pc2 Association with ncRNAs
It has been reported that ncRNA may serve as a component to
form subnuclear bodies and maintain their integrity (Bond and
Fox, 2009). Given that methylated and unmethylated Pc2 are
localized to PcGs and ICGs, respectively, and previous observa-
tions that the chromodomain is capable of binding RNA (Akhtar
et al., 2000), we therefore tested the possibility that Pc2 might
bind specific ncRNAs in these subnuclear structures. By per-
forming in vivo crosslinking and immunoprecipitation proce-
dures (CLIP) using either Pc2K191me2 or Pc2K191 antibodies,
we observed that specific RNA-methylated Pc2 and RNA-unme-
thylated Pc2 complexes were formed after the UV crosslinking,
which was significantly disrupted upon adding the blocking
peptides for Pc2K191me2 and Pc2K191 antibodies in cell lysates
(Figure 5A). Sequence analysis of 94 different clones identified
TUG1, a ncRNA interacting with EZH2 previously identified by
RIP assay (Khalil et al., 2009) and repressing cell-cycle genes,
as the most enriched RNA that interacted with methylated Pc2
(Figure S5A). Surprisingly, in the absence of K191 methylation,
the predominant RNA associated with Pc2 was NEAT2/MALAT1
(Figure S5B), an exclusive signature ncRNA for ICGs (Hutchinson
et al., 2007). Likewise, purified biotinylated TUG1 RNA (nt 117–
3390) harboring the binding sequence identified in the CLIP
assay specifically selected methylated Pc2 from HeLa cell nu-
clear extract, whereas biotinylated NEAT2 RNA (nt 2281–5611)
specifically bound unmethylated Pc2 (Figures 5B, S5C, and
S5D). Electrophoretic mobility shift assays (EMSAs) were next
used to analyze whether a direct switch of Pc2 RNA-binding
preference is observed in response to K191methylation. Incuba-
tion of the TUG1 RNA probe with methylated Pc2 resulted in
specific gel retardation (Figure 5C, first panel, lane 3), whereas
incubation of only a 49 nt NEAT2 RNA probe with unmethylated
Pc2 specifically resulted in gel shift (Figure 5C, third panel,
lane 4). Under these conditions, no shift was observed when
the corresponding TUG1 andNEAT2DNA probes or cold probes
were used (Figures 5C and S5E). We, therefore, conclude that
the interactions of methylated or unmethylated Pc2with ncRNAs
are controlled by a specific covalent modification of Pc2.
ncRNA-Pc2 Interactions Underlie Relocation and
Transcriptional Regulation of Growth-Control Genes
Pc2 has been characterized as a ‘‘reader’’ for the histone code
through its chromodomain (Bernstein et al., 2006). To gain in-
sight into whether binding of ncRNAs affects the histone codereading ability of Pc2, we carried out a modified histone pep-
tide array analysis in an open-ended manner. Consistent with
a previous publication (Bernstein et al., 2006), bacterially purified
chromodomain of Pc2 specifically recognized histone H3K9me3
(Figures 5D andS5F). Strikingly, in the presence of TUG1 ncRNA,
the Pc2 chromodomain now instead read both H4R3me2s and
H3K27me2 (Figures 5E and S5G), which are associated with
global gene repression (Xu et al., 2010). In contrast, by binding
to NEAT2 RNA, Pc2 switched from an H3K9me3 reader to pref-
erentially binding H2AK5ac and H2AK13ac, marks of gene acti-
vation (Figures 5F and S5H). As controls, TUG1 (117–3390) or
NEAT2 (2281–5611) alone failed to bind any histone marks
(Figures S5I and S5J). Collectively, our results now suggest a
mechanism by which ncRNAs can regulate reading of the
histone code by chromatin-binding domains of various regula-
tory cofactors. In this case, ncRNA interacting with a chromodo-
main switches preferential binding from repressive to activation
histone marks.
ICG-specific localization of NEAT2 (Hutchinson et al., 2007)
led us to examine the cellular localization of TUG1 by utilizing
a molecular beacon targeting TUG1. Single-cell nuclear microin-
jection of the TUG1molecular beacon followed by immunostain-
ing suggested that part of TUG1 localization overlapped with
methylated Pc2 staining, suggesting the localization of TUG1
within the PcG bodies (Figure 5G). Thus, the subnuclear struc-
ture-specific localization of TUG1 and NEAT2 may indicate that
they serve as the actual docking sites responsible for relocation
of Pc2-bound growth-control gene promoters. Indeed, knock-
down of TUG1 caused a dramatic redistribution of growth-
control gene promoters out of PcG bodies (Figures 5H and S5K),
which correlated with increased gene expression (Figure 5I)
and cell proliferation, even in the absence of serum (Figure 5J).
Conversely, removal of NEAT2 disrupted the colocalization of
theMCM3gene locuswith ICGs (Figures 5HandS5K) and caused
loss of serum-induced gene expression (Figure 5I) and of cell
proliferation (Figure 5J), although structures of the PcG bodies
and ICGs were not discernibly affected by knocking down TUG1
(Figure S5L) and NEAT2 (Clemson et al., 2009) and serum treat-
ment (Figure S5M).
Next, we used RNA pull-down experiments to identify the
proteins associated with TUG1 and NEAT2. The experiment
performed here calls for washes with buffer containing
1000 mM salt, which definitively results in relatively low back-
grounds in pull-downs and does not disrupt association of
TUG1 and NEAT2 with proteins. MS analysis on proteins pulled
down by biotinylated TUG1 and NEAT2 revealed that TUG1
RNA specifically bound to a number of proteins involved in tran-
scriptional repression, including histone methyltransferases/
demethylases and chromatin modifiers (Figure 5K; Tables S1
and S2), whereas NEAT2 RNA bound to functionally distinctive
cofactors associated with gene activation including transcrip-
tional coactivators, histone methyltransferases/demethylases
associated with transcriptional activation, and pre-mRNA splic-
ing factors (Figure 5K; Tables S1 and S3), suggesting that
ncRNAs may impose a chromatin-remodeling environment by
selectively interacting with chromatin modifier proteins. Intrigu-
ingly, TUG1 interacted with Coronin2A, which is a corepressor
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Figure 4. Relocation of E2F1-Regulated Growth-Control Genes from PcG Bodies to ICGs following Serum Induction
(A–C) Methylated and unmethylated Pc2 exhibit distinct immunostaining patterns with respect to Bmi1 (A) or Ring1A (B) as a marker of PcG bodies and SC35
(C) of ICGs.
(D and E) Serum-induced relocation of growth-control gene locus between PcG bodies and ICGs. HeLa cells were serum-starved followed by restimulation, and
immuno-FISH analyses were performed using antibodies against Pc2K191me2 (D) or Ring1A (E) and FISH probes targeting RBL1 (D) or MCM3 (E).
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LSD1 interacted with NEAT2, consistent with previous observa-
tions that LSD1 colocalizes with transcription units in ICGs
(Hu et al., 2008).
Unmethylated Pc2 Mediates Serum-Induced E2F1
SUMOylation
We next examined the functional roles of unmethylated Pc2 in
growth-control gene activation. Immunoblotting of E2F1 immu-
noprecipitates from denatured cell lysates unexpectedly re-
vealed an upshifted E2F1 band induced by serum stimulation,
which was not due to an E2F1-associated protein but rather
a posttranslational modification (Figures 6A and S6A). Immuno-
blotting using antibody specific against SUMO1 and SUMO2/3
confirmed that E2F1 andE2F6, but not E2F4,wereSUMO1modi-
fied (Figures 6A, S6B, and S6C). In searching for cellular com-
ponents responsible for E2F1 SUMOylation, we observed a
decreased E2F1 SUMOylation with depletion of Ubc9 and Pc2,
but not other candidate E3 ligases tested (Figures 6B and S6D).
When Pc2 was cotransfected with Myc-SUMO1, we observed
a significant increase in E2F1 SUMOylation in vivo (Figure S6E).
The fact that Pc2 directly mediated E2F1 SUMOylation was
further confirmed in vitro (Figure 6C). To map the SUMOylation
site, charge-conserving E2F1 lysine to arginine point mutants
were tested for SUMOylation, revealing that the E2F1 K266R
mutant showed deficient SUMOylation both in vivo and in vitro
(Figures 6D, 6E, and S6F). Although E2F1 and E2F1 K266R local-
ized equally on the promoters of E2F1 target genes, the E2F1
K266Rmutant largely inhibited serum-induced gene expression,
which was not due to any effects of K266R mutation on E2F1
stability or its interaction with Rb (Figures 6F, S6G, and S6H).
Together, these results have revealed a requirement for Pc2-
mediated E2F1 K266 SUMOylation or stabilization of this
SUMOylation for the transcriptional activation of growth-control
genes.
The observation that expression of the Pc2K191R mutant,
which exerted no effects on endogenous levels of Ubc9,
noticeably enhanced E2F1 SUMOylation (Figures 6G and S6I)
led us to explore whether ncRNAs might modulate E2F1
SUMOylation mediated by Pc2. We first tested whether Pc2-
regulated E2F1 SUMOylaton was RNA dependent. Treatment
of Pc2K191me2 immunoprecipitates with RNase I slightly en-
hanced E2F1 SUMOylation, whereas the same treatment im-
paired E2F1 SUMOylation mediated by Pc2K191 immuno-
precipitates (Figure 6H). Consistently, the inhibitory activity of
TUG1 on E2F1 SUMOylation was observed in performing an
in vitro SUMOylation assay, with the addition of TUG1 RNA(F) Effect of knockdown of Pc2, Bmi1, and PHC1 on relocation ofMCM3 locus b
were serum-starved followed by restimulation, and immuno-FISH analyses were
(G) Interaction between endogenous Pc2 and other core components of the PRC1
Ring1A, and PHC1 in HeLa cell extracts. The input represents 10% of the protei
(H) KDM4C is required for serum-induced dissociation of the MCM3 locus from
against KDM4C were serum-starved followed by restimulation, and immuno-FIS
MCM3 locus.
(I) Demethylated Pc2 is required for relocation of the MCM3 locus. HeLa cells m
followed by restimulation, and immuno-FISH analyses were performed using R
analyses on colocalization of MCM3 locus with Ring1A staining (left panel) and S
For (A), (B), (C), (D), and (E), left panels show representative images, and right pa
See also Figure S4.abolishing the enhanced E2F1 SUMOylation mediated by meth-
ylated Pc2 (Figure 6I, right panel, lane3). Taken together, our
findings suggest that Pc2-mediated E2F1 SUMOylation at
K266, which was modulated by interactions with ncRNAs, is re-
quired for the activation of cell-growth-control genes in response
to serum.
CDCA7L Links E2F1 SUMOylation and H2B
Ubiquitination in Growth-Control Gene Activation
The functional binding of SUMOylated proteins to the SUMO-
interacting motif (SIM)-containing proteins plays critical roles in
many biological processes including transcriptional activation,
cell growth/differentiation, and DNA-damage response (Ker-
scher, 2007). Thus, we searched for the potential SIM-containing
proteins that can recognize the E2F1 K266 SUMOylation and its
functional role in regulating growth-control gene activation.
Analysis by MS of a protein exclusively copurified with WT
E2F1, but not the K266R mutant, identified it as CDCA7L/
JPO2/RAM2 (Figures 7A, S7A, and S7B), a cell-cycle regulator
with a conserved RING domain (Huang et al., 2005). The spe-
cific interaction between SUMOylated E2F1 and CDCA7L was
mediated by a SIM located N-terminal of CDCA7L, and muta-
tions in this motif (V100/103A) abolished the interaction with
SUMOylated E2F1 (Figure 7B). Consistent with the specific
recruitment of CDCA7L on the E2F1 target gene promoters
upon serum stimulation (Figure 7C), knockdown of CDCA7L by
shRNAs blocked serum-induced expression of E2F1 target
genes (Figures 7D and S7C). CDCA7L possesses a conserved
RING finger domain, a characteristic of RING-class E3 ubiquitin
protein ligases (Deshaies and Joazeiro, 2009). We therefore
screened potential substrates of CDCA7L by both in vivo and
in vitro ubiquitination assay, finding that CDCA7L strongly stimu-
lated H2Bmonoubiquitination at K120 (Figures S7D–S7F). These
results indicate that theRING finger of CDCA7L is required for the
monoubiquitination of H2B, and perhaps additional substrates,
critical for transcriptional activation of growth-control genes.
Analysis by ChIP assay of UbH2B and H2B enrichment re-
vealed that ubiquitination of H2B was enhanced at the E2F1-
binding sites upon serum stimulation, which was diminished
with knockdown of CDCA7L (Figure 7E). This finding is consis-
tent with the previous notion that UbH2B correlates with gene
activation and transcriptional elongation (Minsky et al., 2008).
Together, these data revealed that a series of covalent modifica-
tions initiated by Pc2-mediated SUMOylation of E2F1 leads to
the subsequent H2B ubiquitination and the activation of a cohort
of growth-control genes.etween PcG bodies and ICGs. HeLa cells microinjected with indicated siRNAs
performed using antibodies and FISH probes as indicated.
complex demonstrated by coimmunoprecipitation of Pc2K191me2 with Bmi1,
n amount used for immunoprecipitation.
PcG bodies. HeLa cells microinjected with control siRNA or validated siRNA
H analyses were performed using Ring1A antibodies and probes targeting the
icroinjected with blank vector, Pc2 WT, or K191R mutant were serum-starved
ing1A, SC35 antibodies, and probes targeting the MCM3 locus. Statistical
C35 staining (right panel) were shown.
nels show statistical analyses. Mean ± SEM, *p < 0.05 and **p < 0.01.
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Figure 5. ncRNA-Pc2 Interactions Underlie Relocation and Transcriptional Activation of Growth-Control Genes
(A) Methylated and unmethylated Pc2 bind to RNAs. CLIP assays using Pc2K191me2 (left panel) or Pc2K191 (right panel) antibodies were performed, and specific
protein-RNA complexes (indicated by red box) were visualized by autoradiography.
(B) Validation of interactions of TUG1 andNEAT2with Pc2. In vitro transcribed biotinylated TUG1RNA (left panel) orNEAT2RNA (right panel) were incubated with
HeLa nuclear extract. The elution of Monoavadin beads was subjected to immunoblotting with indicated antibodies.
(C) The selective binding of Pc2 to TUG1 or NEAT2 depends on K191 methylation state. RNA gel shift assay was performed using synthesized TUG1 and NEAT2
RNA and their corresponding DNA oligos and recombinant His-Pc2 with or without in vitro methylation.
(D–F) TUG1 and NEAT2 function as modulators of Pc2 chromodomain for ‘‘reading’’ the histone code. modified histone peptide array was incubated with
recombinant His-Pc2 chromodomain in the presence of yeast tRNA (D), in vitro transcribed TUG1 (117–3390) (E), or NEAT2 (2281–5611) (F) RNA fragments and
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DISCUSSION
Orchestrating precise spatial and temporal patterns of gene
expression is crucial for the normal development of all organisms
and maintenance of homeostasis. DNA-binding transcription
factors, chromatin modifiers, and dynamic positioning of par-
ticular loci in nuclei are all essential to establish precise tran-
scriptional regulation and achieve the correct patterns of gene
expression. Here, we have elucidated how a nonhistone methyl-
ation event and the resultant specific ncRNA associations
spatially modulate signal-induced nuclear architecture alter-
ation, which underlies regulation of transcription units controlling
cell-growth programs in both normal and transformed cells.
Our studies have revealed that the methylation/demethylation
of a single protein associated with E2F1-bound growth-control
genes, Pc2, is responsible for the physical relocation of these
transcription units from PcG bodies, in which their expression
is repressed, to ICGs, in which their expression is activated (Fig-
ure 7F). Unexpectedly, this reflects the differential interactions of
methylated versus unmethylated Pc2 with two distinct ncRNAs
that are located in distinct subnuclear architectural compart-
ments (Figure 7F). In the case of Pc2, methylation controls the
protein’s interaction with two distinct ncRNAs, TUG1 and
NEAT2, which results in the exclusive subnuclear localization
of methylated and unmethylated Pc2 in PcG bodies and ICGs,
respectively. Methylated Pc2 may represent an important anti-
mitogenic signal and, under certain stimuli, a stress-induced
modification mark required for growth-control gene repres-
sion and senescence, whereas unmethylated Pc2 is essential
for physiological growth-control gene expression and cell
proliferation.
TUG1, previously reported to interact with the PRC2 complex
(Khalil et al., 2009), is localized in PcG bodies to serve as a scaf-
fold by interacting with Suv39h1-methylated Pc2, which relo-
cates growth-control transcription units and brings them in prox-
imity with specific corepressor machinery. In contrast, NEAT2
interacts with several proteins associated with gene activation.
These ncRNAs promote the relocation of growth-control genes
in response to mitogenic signals and are likely to facilitate the
repression/activation of the encoded transcription units based
both on their association with multiple coregulating complexes
and on actions to modulate histone marks preferred by
‘‘readers’’ of the histone code. Indeed, the loss of TUG1 causes
signal-independent activation of growth by failure to recruit
growth-control gene loci to PcG bodies, whereas, conversely,subjected to immunoblotting with indicated antibodies. The Myc tag antibody was
binding specificity calculated by Array Analyses Software based on two arrays (i
(G) TUG1 is localized in PcG bodies. HeLa cells microinjected with molecul
Pc2K191me2 antibodies.
(H) TUG1 andNEAT2 are required for serum-induced relocation of theMCM3 locu
serum-starved followed by restimulation, and immuno-FISH analyses were perfo
Statistical analyses on colocalization of MCM3 loci with Ring1A staining (left pan
(I and J) Effect of TUG1 or NEAT2 knockdown on serum-induced growth-contro
NEAT2 siRNA were serum-starved followed by restimulation, and relative mRNA
and flow cytometry (J).
(K) A list of TUG1 and NEAT2 ncRNA-associated proteins identified from two ind
Mean ± SEM, *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S5 and Tathe loss ofNEAT2 inhibits growth, even in the presence of growth
signals, with a failure to relocate the growth-control genes
to ICGs.
This dynamic process is apparently dependent on a histone
demethylase, KDM4C, that facilitates signal-dependent reloca-
tion of growth-control genes between distinct subnuclear archi-
tectural structures, with two ncRNAs serving as subnuclear
molecular scaffolds. Our data have thus identified Pc2-ncRNA
interactions as a key mechanism that determines the relative
positioning of a growth-control gene regulatory program with
respect to subnuclear architectural structures; however, we
cannot absolutely exclude the possibility of a rapid assembly
of subnuclear architectural structures in situ on the regulated
promoters.
Consistent with our ncRNA pull-down results, the promoters
interacting with TUG1 are postulated to present multiple epige-
nomic regulators that might also modulate histone marks, in-
cluding the H3K9 methyltransferase RIZ1, the H3K27 methyl-
transferase EZH2, and the H3K4 demethylase JARID1A. In
contrast, the promoters associated with NEAT2 in ICGs ex-
hibit low levels of H3K9me2/3 but high levels of H3K36me3 and
H3K4me3, perhaps regulated by interaction of NEAT2 with
LSD1, SET2, and MLL. These data suggest the potential impor-
tance of these two ncRNAs as platforms for organizing a coordi-
nated repression or activation program, respectively.
Taken together, our findings highlight the large network of
long ncRNAs, together with their associated protein complexes,
as key components of the subnuclear architectural struc-
tures, each acting as a ‘‘sensor’’ for specific cohorts of regulated
gene programs in response to signal-induced modifications
that license gene-regulatory region-ncRNA interactions. Al-
though Pc2 methylation appears to be the key determinant for
relocation of growth-control genes, based on a methylation/
demethylation-dependent switch in preference for TUG1 or
NEAT2 interactions, respectively, we are tempted to speculate
that other ncRNAs recognize covalent modifications of other
gene-associated proteins and exert their ncRNA scaffold func-
tions in distinct subnuclear compartments to act as sensors for
many regulated signaling pathways, and as modulators of
‘‘reading’’ marks on histone tails for a variety of chromodomain-
containing proteins and other histone code ‘‘readers.’’
Future exploration of interactions between subnuclear struc-
ture-specific ncRNAs and functionally distinctive protein cohorts
is likely to uncover fresh insights into central strategies in devel-
opment, homeostasis, and disease.added to detect Myc-tagged peptides on position P21 as positive control. The
mages shown in Figures S5F–S5H) was shown.
ar beacon probes targeting TUG1 were subjected to immunostaining with
s. HeLa cellsmicroinjectedwith validated siRNA targeting TUG1 orNEAT2were
rmed using Ring1A, SC35 antibodies, and probes targeting the MCM3 locus.
el) and SC35 staining (right panel) are shown.
l gene expression and cell proliferation. HeLa cells transfected with TUG1 or
levels of indicated genes and cell proliferation were determined by qRT-PCR (I)
ependent MS experiments.
bles S1, S2, and S3.
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Figure 6. Pc2-Mediated E2F1 SUMOylation Is Required for Growth-Control Gene Activation
(A) Serum-induced E2F1 SUMOylation. HeLa cells were serum-starved followed by restimulation, and the cell lysates were immunoprecipitated with E2F1
antibodies under denaturing conditions followed by immunoblotting with antibodies indicated.
(B) Pc2 promotes E2F1 SUMOylation in vivo. HeLa cells were transfected with indicated siRNAs/plasmids, and the cell lysates were immunoprecipitated with
E2F1 antibodies under denaturing conditions followed by immunoblotting with E2F1 (left panel) or Myc tag (right panel) antibodies.
(C) Pc2 promotes E2F1 SUMOylation in vitro. Bacterially expressed His-Pc2 and His-E2F1 were incubated with recombinant E1, E2, and SUMO1 or SUMO1
mutant. The reactions were separated by SDS-PAGE followed by Coomassie blue staining (left panel) and immunoblotting with E2F1 (middle panel) or SUMO1
(right panel) antibodies.
(D and E) E2F1 is SUMOylated at lysine 266. HeLa cells were transfected with WT or single K mutated E2F1 (D) or K266R mutant (E) as indicated, and the cell
lysates were immunoprecipitated with FLAG antibodies under denaturing conditions followed by immunoblotting with E2F1 (upper panel) or Myc tag (bottom
panel) antibodies (D) and E2F1 (left panel) or SUMO1 (right panel) antibodies (E).
(F) E2F1 SUMOylation on growth-control gene promoters. HeLa cells were transfected with indicated plasmids followed by two-step ChIP analyses using FLAG
and SUMO1 antibodies on indicated regions.
(G) K191 methylation inhibits Pc2-mediated E2F1 SUMOylation in vivo. HeLa cells were transfected with indicated plasmids, and the cell lysates were immu-
noprecipitated with E2F1 antibodies under denaturing conditions followed by immunoblotting with E2F1 (left panel), Myc tag (middle panel), or SUMO1 (right
panel) antibodies.
(H) Pc2-mediated E2F1 SUMOylation is RNA dependent. Immunoprecipitates of Pc2K191me2 or Pc2K191 from HeLa cells (right panel) were incubated with
His-tagged E2F1, recombinant E1, E2, and SUMO1 or SUMO1 mutant with or without RNase I treatment. The reaction products were subjected to immuno-
blotting using antibodies targeting E2F1 (left panel).
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EXPERIMENTAL PROCEDURES
Cell Culture
Human cervical cancer cell line HeLa, embryonic kidney cell line HEK293T,
and human lung normal fibroblast IMR-90 were obtained from American
Type Culture Collection (ATCC) and were cultured under standard conditions.
Transfection of HeLa cells with siRNA and plasmid DNA was performed using
Lipofectamine 2000 (Invitrogen). To induce growth-control gene expression
and cell proliferation, HeLa cells transfected with plasmids or siRNAs as indi-
cated were starved in serum-free media for 48 hr followed by stimulation with
complete serum media for an additional 16 hr. IMR-90 fibroblasts were incu-
bated in DMEM (GIBCO) medium supplemented with a suboptimal concentra-
tion of FBS (0.1%) for 4 days. Normal serum level (10%)was restored, and cells
were harvested at 24 hr after release from low serum. A detailed description of
methods is included in the Extended Experimental Procedures.
Antibody Generation
The rabbit anti-dimethyl-Pc2-specific antibody (Pc2K191me2) was raised
against a synthetic peptide CPDLGA (dimethyl-K) SHPPDKWAQ based on
the human Pc2 sequence flanking lysine 191 (Abgent). The rabbit anti-unme-
thylated Pc2 antibody (Pc2K191) was obtained at the same time against
peptide CPDLGAKSHPPDKWAQ (Abgent). The Pc2K191me2 and Pc2K191
antibodies were used for immunoprecipitation, immunoblotting, ChIP, CLIP,
and immunofluorescence.
Cell Proliferation Assay
Cell proliferation was measured by using the Click-iT EdU Cell Prolifera-
tion Assay Kit (Invitrogen) following the manufacturer’s protocol. Data were
recorded on a BD LSR II Flow Cytometer and analyzed by FlowJo flow cytom-
etry analysis software (Tree Star, Inc.).
Immunofluorescence and Colocalization Analyses
Immunofluorescence of HeLa cells was carried out as previously described
(Liu et al., 2010). Images were acquired with a Zeiss Axioplan 2MOT Epifluor-
escent microscope (Carl Zeiss, Inc) and Hamamatsu ORCA ER black/white
CCD camera in 633 oil immersion objective with each channel recorded
once and all channels overlapped to generate overall images. For Ring1/
Bmi1 and Pc2K191me2 immunofluorescence, rabbit anti-Ring1/Bmi1 and
anti-Pc2K191me2 IgGs were labeled by Zenon Alexa Fluor 594 and 488 Rabbit
IgG Labeling Kits, respectively (Molecular Probe).
Quantification of colocalization was determined by Pearson’s correlation
coefficient using commercially available Colocalizer Pro software, and the
analysis was performed on at least 100 cells per condition with three indepen-
dent experiments.
Immunofluorescence In Situ Hybridization
Cell nuclei isolation and immuno-FISH were carried out according to a method
previously described (Lavrov et al., 2004), and the probes were commercially
labeled by Empire Genomics and are listed in Extended Experimental Proce-
dures. At least 100 cells were counted in each experiment for statistical
analysis.
In Vivo Crosslinking and Immunoprecipitation Assay
CLIP analyses of methylated and unmethylated Pc2 were performed as previ-
ously described (Ule et al., 2005). Briefly, cells were ultraviolet (UV) irradiated to
covalently crosslink RNA-protein complexes. After UV irradiation, cells were
lysed, and the RNA was partially digested, allowing a small fragment to remain
attached to protein. RNA-protein complexes of interest were then partially
purified by immunoprecipitation, and noncovalently associated RNAs were re-
moved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-(I) TUG1 and NEAT2 regulate Pc2-mediated E2F1 SUMOylation. Bacterially ex
mutant), and His-Pc2 (unmethylated or methylated) in the presence of synthesized
to immunoblotting using antibodies against E2F1.
See also Figure S6.PAGE). These purified RNA-protein complexes were isolated and treated
with proteinase K, which removes protein but leaves intact RNAs. The recov-
ered RNAs were subjected to RNA linker ligation, RT-PCR amplification, and
sequencing.
Molecular Beacon and RNA FISH
Custom-designed molecular beacon targeting TUG1 was synthesized by
IDT. RNA FISH was performed using Stellaris RNA FISH technology according
to manufacturer’s instruction (Biosearch Technologies, Inc.). Stellari RNA
FISH probes targeting TUG1 and NEAT2 were designed at http://www.
singlemoleculefish.com/designer.html.
Data Analysis and Statistics
Relative quantities of gene expression level were normalized toActin. The rela-
tive quantities of ChIP samples were normalized by individual inputs, respec-
tively. Results are reported as mean ± standard error of the mean (SEM) of
three independent experiments. Comparisons were performed using two-
tailed paired Student’s t test. *p < 0.05, **p < 0.01, and ***p < 0.001.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and three tables and can be found with this article online at doi:10.
1016/j.cell.2011.08.054.
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